Top Markets
#1 Pleasing Gold Pleasing Gold +601.59%
#2 Islamic Coin Islamic Coin +154.12%
#3 PulseChain PulseChain +52.83%
#4 BOOK OF MEME BOOK OF MEME +41.48%
#5 DogBull DogBull +36.81%
#6 Neiro Neiro +24.76%
#7 Nockchain Nockchain +22.48%
#8 ORDI ORDI +19.01%
#9 SkyAI SkyAI +16.82%
#10 Monad Monad +16.62%
Coin of the day
Pleasing Gold Pleasing Gold
Innstillinger
Språk
NORSK
Valuta
USD
Tema
Grace Therapeutics, Inc. Grace Therapeutics, Inc.

Grace Therapeutics, Inc.

GRCE
Rangering i aksjer #27034
Grace Therapeutics, Inc. specializes in the creation and commercialization of... Grace Therapeutics, Inc. specializes in the creation and commercialization of pharmaceutical products, primarily targeting uncommon and neglected diseases, with operations centered in Canada. The company's most advanced experimental treatment is GTX-104, an intravenous infusion designed to address subarachnoid hemorrhage. Its development pipeline further includes GTX-102, an oral mucosal betamethasone spray intended for the management of ataxia-telangiectasia, and GTX-101, a topical bioadhesive film-forming bupivacaine spray for postherpetic neuralgia. Established in 2002, the enterprise previously operated under the name Acasti Pharma Inc., before officially adopting Grace Therapeutics, Inc. in October 2024. The company's main offices are located in Princeton, New Jersey.
Aksjekurs
$2.18
Sist synkronisert: 2026-08-19
Markedsverdi
$35.55M
Endring (1 dag)
2.57%
Endring (1 år)
-33.19%
Land
US
Handel Grace Therapeutics, Inc. (GRCE)

Kategori

Healthcare
Inntekter for Grace Therapeutics, Inc. (GRCE)
Inntekter i 2026 TTM: 0
Ifølge Grace Therapeutics, Inc. sine nyeste økonomiske rapporter er selskapets nåværende resultat 0. I 2026 hadde selskapet et resultat på 0, lik resultatet i 2026, som var 0. Resultatet som vises på denne siden er resultat før renter og skatt, eller EBIT.
Inntektshistorikk for Grace Therapeutics, Inc. fra 2026 til 2026
Inntekter ved slutten av hvert år
År Inntekter Endre
Ikke nok data for de angitte datoene.
Inntekter for lignende selskaper eller konkurrenter
Selskap Inntekter Forskjell i inntekter Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
$1.61B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH